Trial Profile
Anti-TNF treatment in patients with chronic low back pain associated with Modic I changes: An exploratory trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Oct 2022
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Back pain
- Focus Therapeutic Use
- 28 Sep 2016 New trial record